| RS2540168609 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2540168616 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540169004 |
COL2A1
|
Health Risk |
Likely pathogenic |
Kniest dysplasia, Stickler syndrome type 1 |
| RS2540169027 |
COL2A1
|
Health Risk |
Likely pathogenic |
COL2A1-related disorder, COL2A1-related disorder |
| RS2540169048 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540169164 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540169171 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540170430 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540170618 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS2540170621 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Telangiectasia |
| RS2540170652 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540170764 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS2540170766 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540170879 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Hereditary hemorrhagic telangiectasia, Hereditary hemorrhagic telangiectasia |
| RS2540170898 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Hereditary hemorrhagic telangiectasia, Hereditary hemorrhagic telangiectasia |
| RS2540170917 |
ACVRL1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540170936 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS2540172615 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540172670 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540172722 |
SCN8A
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2540172754 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540172793 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540172917 |
SCN8A
|
Health Risk |
Pathogenic |
— |
| RS2540172993 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540174456 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS2540174463 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540174470 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540174495 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome, type I |
| RS2540174508 |
COL2A1
|
Health Risk |
Likely pathogenic |
Type 2 collagenopathy, Type 2 collagenopathy |
| RS2540174515 |
ACVRL1
|
Health Risk |
Pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS2540174549 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Telangiectasia |
| RS2540174605 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540174635 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540174647 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540174681 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540174684 |
ACVRL1
|
Health Risk |
Likely pathogenic |
ACVRL1-related disorder, ACVRL1-related disorder |
| RS2540174697 |
ACVRL1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Telangiectasia |
| RS2540174718 |
ACVRL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Telangiectasia |
| RS2540175271 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540175331 |
COL2A1
|
Health Risk |
Likely pathogenic |
Platyspondylic dysplasia, Torrance type |
| RS2540175371 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540175512 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540175543 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome type 1, Spondyloepiphyseal dysplasia congenita |
| RS2540176622 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2540177679 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540177721 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome, type I |
| RS2540177848 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540179907 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2540179988 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540180043 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540180528 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540180615 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540180667 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540181315 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540181410 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540181466 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540181480 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540181556 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540182079 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540182212 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540182221 |
PEX5
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540182543 |
PEX5
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2540182684 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540182818 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540182834 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540182840 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540183519 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stickler syndrome type 1, COL2A1-related disorder |
| RS2540183536 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540183604 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540183621 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS2540184329 |
SCN8A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2540184376 |
SCN8A
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540185916 |
SCN8A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2540186185 |
SCN8A
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2540187271 |
COL2A1
|
Health Risk |
Likely pathogenic |
Achondrogenesis type II, Achondrogenesis type II |
| RS2540187424 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540187489 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540187525 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540187694 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540187705 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540187828 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540187904 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2540187950 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS2540194058 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540194271 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS2540221503 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2540221717 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2540221793 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2540231164 |
TRAPPC9
|
Health Risk |
Likely pathogenic |
TRAPPC9-related disorder, TRAPPC9-related disorder |
| RS2540234162 |
PYROXD1
|
Health Risk |
Pathogenic |
— |
| RS2540239327 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 13 |
| RS2540240013 |
OPLAH
|
Health Risk |
Pathogenic |
5-Oxoprolinase deficiency, 5-Oxoprolinase deficiency |
| RS2540242461 |
OPLAH
|
Health Risk |
Likely pathogenic |
5-Oxoprolinase deficiency, 5-Oxoprolinase deficiency |
| RS2540244241 |
APOA5;ZPR1
|
Health Risk |
Likely pathogenic |
Hypertriglyceridemia 1, Hypertriglyceridemia 1 |
| RS2540244684 |
HK1
|
Health Risk |
Likely pathogenic |
— |
| RS2540246645 |
APOA5
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2540247952 |
OPLAH
|
Health Risk |
Likely pathogenic |
5-Oxoprolinase deficiency, 5-Oxoprolinase deficiency |
| RS2540248611 |
PYROXD1
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS2540251593 |
AICDA
|
Health Risk |
Likely pathogenic |
Hyper-IgM syndrome type 2, Hyper-IgM syndrome type 2 |
| RS2540254262 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |